Pierce™ Anti-DYKDDDDK Magnetic Agarose
Invitrogen17万+抗体限时买二赠一,靶点广,灵活用!
Pierce™ Anti-DYKDDDDK Magnetic Agarose
Thermo Scientific™

Pierce™ Anti-DYKDDDDK Magnetic Agarose

Thermo Scientific™ Pierce™ Anti-DYKDDDK Magnetic Agarose Beads provide a fast, convenient method for purification of DYKDDDK-tagged recombinant proteins
Have Questions?
Change viewbuttonViewtableView
Catalog NumberQuantity
A367974 mL
A3679820 mL
Catalog number A36797
Price (CNY)
3,574.00
Online Exclusive
Ends: 27-Dec-2025
5,758.00
Save 2,184.00 (38%)
Each
Add to cart
Quantity:
4 mL
Price (CNY)
3,574.00
Online Exclusive
Ends: 27-Dec-2025
5,758.00
Save 2,184.00 (38%)
Each
Add to cart

Thermo Scientific Pierce Anti-DYKDDDDK Magnetic Agarose provides a fast, convenient method for purification and immunoprecipitation (IP) of DYKDDDDK-tagged proteins from in vitro protein expression systems, bacteria, yeast, and mammalian cells. The amino acid sequence DYKDDDDK, commonly known as 'FLAG', is recognized by a high-affinity rat monoclonal antibody (clone L5) that is covalently attached to a magnetite-embedded agarose core particle.

For protein purification, the magnetic agarose is added to a sample containing DYKDDDDK-tagged proteins with the tag on either the N- or the C-terminus. Captured proteins are then magnetically separated from the supernatant, and non-specifically bound proteins can be washed away before dissociating bound DYKDDDDK-tagged proteins with elution buffer. The magnetic agarose is removed from the solution using a magnetic stand or an instrument such as the KingFisher Flex Magnetic Particle Processor. Automated instruments are especially useful for higher throughput purifications and screening of purification conditions.

Features include:

  • Specific—unique base beads and highly specific antibody minimizes off-target binding (low non-specific binding)
  • High purity—optimized bind-wash-elute protocol enables high purity
  • High yield—special antibody conjugation method enables high yield
  • Rapid—entire purification protocol typically takes less than 40 mins
  • Economical—purification protocol allows multiple reuses
  • Versatile—beads are compatible with manual and automated workflows (e.g., KingFisher instruments)

Characteristics of Pierce Anti-DYKDDDDK Magnetic Agarose:

  • Composition: anti-DYKDDDDK antibody covalently attached to a magnetic, highly crosslinked agarose support
  • Magnetization: ferrimagnetic with low remanence
  • Bead size: 10–40 μm
  • Bead concentration: 25% slurry in phosphate buffered saline, 0.01% Tween-20 detergent, 0.02% sodium azide, pH 7.2
  • Binding capacity: ≥3.2 mg DYKDDDDK-tGFP-His protein (∼32 kDa)/mL settled beads
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Bed Volume1 mL
Capacity4 mL
FormLiquid
FormatLiquid
FormulationSlurry: 25%
Particle Size25 to 30 μm
Product LinePierce
Product TypeMagnetic Agarose
Quantity4 mL
Shipping ConditionWet Ice
Stationary PhaseAnti-DYKDDDDK monoclonal antibodies
MatrixMagnetic Agarose
Unit SizeEach
Contents & Storage
1 mL settled beads. 4 mL supplied as a 25% suspension in PBS containing 0.02% sodium azide.

Store at 2–8°C.

Frequently asked questions (FAQs)

How does Pierce Anti-DYKDDDDK Magnetic Agarose (Cat. No. A36797, A36798) work for purification of DYKDDDK-tagged recombinant proteins?

The amino acid sequence DYKDDDDK, commonly known as the ''Flag'' epitope group, is recognized by a high-affinity rat monoclonal antibody (clone L5) that is covalently attached to a magnetite-embedded agarose core particle.

For protein purification, the magnetic agarose is added to a sample containing DYKDDDDK-tagged proteins with the tag on either the N- or the C-terminus. Captured proteins are then magnetically separated from the supernatant, and non-specifically bound proteins can be washed away before dissociating bound DYKDDDDK-tagged proteins with elution buffer. The magnetic agarose is removed from the solution using a magnetic stand or an instrument such as the KingFisher Flex Magnetic Particle Processor. Automated instruments are especially useful for higher-throughput purifications and screening of purification conditions.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

What is the slurry/suspension percentage for your anti-DYKDDDDK ("FLAG") products?

Anti-DYKDDDDK Magnetic Agarose (Cat. Nos. A36797, A36798, A36799B) is offered as a 25% suspension (1 mL of 25% suspension = 0.25 mL of settled beads). UltraLink-based Anti-DYKDDDDK Affinity Resin (Cat. Nos, A36801, A36803, A36804) is offered as a 50% slurry (1 mL of 50% slurry = 0.5 mL of settled resin).

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

What is the binding capacity for your Anti-DYKDDDDH Magnetic Agarose?

Here is the binding capacity: ≥3.2 mg DYKDDDDK-tGFP-His protein (˜32kDa)/mL settled beads.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

How do I cleave off the DYKDDDDK ("FLAG") tag after purification?

An enterokinase cleavage site behind the DYKDDDDK (“FLAG”) tag can allow complete removal of the DYKDDDDK (“FLAG”) tag leaving no additional amino acids. We offer EKMax Enterokinase (Cat. Nos. E18001 and E18002) that can be used for this purpose. Subsequently, the EKMax Enterokinase can be removed using EK-Away Resin (Cat. No. R18001), a resin conjugated with soybean trypsin inhibitor, which has high affinity for enterokinase.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

Citations & References (8)

Citations & References
Abstract
NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway.
Authors:Yin S,Zhao S,Li J,Liu K,Ma X,Zhang Z,Wang R,Tian J,Liu F,Song Y,Song M,Zhao R,Yang R,Lee MH,Dong Z
Journal:Cellular and molecular life sciences : CMLS
PubMed ID:37462735
Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide with a low survival rate due to a lack of therapeutic targets. Here, our results showed that nuclear mitotic apparatus protein 1 (NUMA1) transcript and protein levels are significantly upregulated in ESCC patient samples and its high expression predicated poor ... More
A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
Authors:Xia Q,Du Z,Chen M,Zhou X,Bai W,Zheng X,Lin L,Zhao Y,Ding J,Wu Z,Zou H,Wang S,Xu L,Li E,Wu B
Journal:Molecular oncology
PubMed ID:37753805
During malignant tumour development, the extracellular matrix (ECM) is usually abnormally regulated. Dysregulated expression of lysyl oxidase-like 2 (LOXL2), matrix metalloproteinase 9 (MMP9) and lipocalin 2 (LCN2) are associated with ECM remodelling. In this study, protein-protein interaction assays indicated that LCN2 and LOXL2 interactions and LCN2 and MMP9 interactions occurred ... More
RUFY3 and RUFY4 are ARL8 effectors that promote coupling of endolysosomes to dynein-dynactin.
Authors:Keren-Kaplan T,Sarić A,Ghosh S,Williamson CD,Jia R,Li Y,Bonifacino JS
Journal:Nature communications
PubMed ID:35314674
The small GTPase ARL8 associates with endolysosomes, leading to the recruitment of several effectors that couple endolysosomes to kinesins for anterograde transport along microtubules, and to tethering factors for eventual fusion with other organelles. Herein we report the identification of the RUN- and FYVE-domain-containing proteins RUFY3 and RUFY4 as ARL8 ... More
Immunoprecipitation Strategies to Isolate RIPK1/RIPK3 Complexes in Mouse Macrophages
Authors:Siokas I, Zhang D, Poltorak A, Muendlein H, Degterev A
Journal:Curr Protoc.
PubMed ID:
Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities
Authors:Kamal L, Pierce SB, Canavati C, Rayyan AA, Jaraysa T, Lobel O, Lolas S, Norquist BM, Rabie G, Zahdeh F, Levy-Lahad E, King M-C, Kanaan, MN
Journal:Cold Spring Harb Mol Case Stud
PubMed ID: